Cost-effectiveness (CE) analysis of interferon-alpha in high-risk melanoma patients

被引：1
|
作者：
Ding, M
Xing, Y
Shih, T
Cox, D
Cantor, S
Cormier, J
机构：
[1] Rice Univ, Houston, TX 77251 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62070-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanoma
    Hillner, BE
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S18 - S21
  • [22] Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients
    Adrian D. Griffin
    Andrew S. Perry
    Douglas M. Fleming
    [J]. PharmacoEconomics, 2001, 19 : 293 - 301
  • [23] Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients
    Griffin, AD
    Perry, AS
    Fleming, DM
    [J]. PHARMACOECONOMICS, 2001, 19 (03) : 293 - 301
  • [24] Cost-effectiveness of ramipril in preventing cardiovascular events in high-risk patients
    Ganguly, R
    Parasuraman, TV
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 321 - 322
  • [25] Malignant melanoma - Interferon alpha: an important option in the therapy of high-risk patients
    不详
    [J]. HAUTARZT, 2005, 56 (12): : 1190 - 1190
  • [26] Cost-effectiveness analysis of dinutuximab ß for the treatment of high-risk neuroblastoma in China
    Shen, An-Le
    Zhao, Jie
    Yu, Li-Ting
    Zhang, An-An
    Wu, Bin
    Fang, Ye
    Han, Ya-Li
    Li, Chen-Sui-Zi
    Li, Zhi-Ling
    Gao, Yi-Jin
    Zhang, Shun-Guo
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [27] Cost-Effectiveness Analysis of High-Risk Groups Tuberculosis Screening in Malaysia
    Hassan, Nor Zam Azihan Mohd
    Razali, Asmah
    Shahari, Mohd Ridzwan
    Kunusagaran, Mohd Shaiful Jefri Mohd Nor Sham
    Halili, Juanita
    Zaimi, Nur Amalina
    Bahari, Mohd Shahri
    Aminuddin, Farhana
    [J]. FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [28] Cost-effectiveness of 12-months of interferon-alpha treatment for chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Gross, JB
    Dickson, ER
    Evans, RW
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A1233 - A1233
  • [29] Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Hermans, JE
    Therneau, TM
    Dickson, ER
    Evans, RW
    Gross, JB
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) : 866 - +
  • [30] Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients
    Van Gool, AR
    Fekkes, D
    Kruit, WHJ
    Mulder, PGH
    Ten Hagen, TLM
    Bannink, M
    Maes, M
    Eggermont, AMM
    [J]. PSYCHIATRY RESEARCH, 2003, 119 (1-2) : 125 - 132
12345